Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0000950170-25-032125

EVP, Chief Medical Officer acquired 43,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lebwohl David · EVP, Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-01 Grant or award : show line 1 in the form +43,200 130,866 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-01 Grant or award : show line 2 in the form Stock Option (right to buy) +61,714 61,714 D
Loading xslF345X05/ownership.xml…